|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Tracking Information | |
|---|---|
| First Received Date ICMJE | November 2, 1999 |
| Last Updated Date | October 1, 2007 |
| Start Date ICMJE | |
| Primary Completion Date | |
| Current Primary Outcome Measures ICMJE | |
| Original Primary Outcome Measures ICMJE | |
| Change History | Complete list of historical versions of study NCT00002352 on ClinicalTrials.gov Archive Site |
| Current Secondary Outcome Measures ICMJE | |
| Original Secondary Outcome Measures ICMJE | |
| Descriptive Information | |
| Brief Title ICMJE | A Study of Lobucavir in Patients With AIDS |
| Official Title ICMJE | Pilot Study of the Antiviral Activity of Multiple Doses of Oral Lobucavir in AIDS Patients |
| Brief Summary | The purpose of this study is to see if lobucavir is a safe and effective treatment for cytomegalovirus in patients with AIDS. |
| Detailed Description | Patients receive 1 of 2 doses of lobucavir for 28 days, with 2 weeks of follow-up. Weekly clinic visits are required. |
| Study Phase | |
| Study Type ICMJE | Interventional |
| Study Design ICMJE | Treatment, Dose Comparison, Safety Study |
| Condition ICMJE |
|
| Intervention ICMJE | Drug: Lobucavir |
| Study Arms / Comparison Groups | |
| Publications * | |
|
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|
| Recruitment Information | |
| Recruitment Status ICMJE | Completed |
| Enrollment ICMJE | 30 |
| Completion Date | |
| Primary Completion Date | |
| Eligibility Criteria ICMJE | Inclusion Criteria Concurrent Medication: Allowed:
Patients must have:
Exclusion Criteria Co-existing Condition: Patients with the following symptoms or conditions are excluded:
Patients with the following prior conditions are excluded:
Prior Medication: Excluded within 4 weeks prior to study entry:
Prior Treatment: Excluded within 4 weeks prior to study entry:
|
| Gender | Both |
| Ages | 18 Years and older |
| Accepts Healthy Volunteers | No |
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects |
| Location Countries ICMJE | United States |
| Administrative Information | |
| NCT ID ICMJE | NCT00002352 |
| Responsible Party | |
| Study ID Numbers ICMJE | 248A, AI459-007 |
| Study Sponsor ICMJE | Bristol-Myers Squibb |
| Collaborators ICMJE | |
| Investigators ICMJE | |
| Information Provided By | Bristol-Myers Squibb |
| Verification Date | October 2007 |
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|